commercializes innovative medicines in areas of unmet need. With each new discovery and
experimental drug candidate, they seek to improve the care of patients suffering from life-threatening
diseases. Gilead's primary areas of focus include HIV/AIDS, Liver Disease, Hematology/Oncology,
Cardiovascular and Inflammation/Respiratory Conditions.
Specialties and Expertise:Biopharma, Biotechnology, Health Care, Pharmaceutical, Medicines Development, Medicine Manufacturing,
Hematology, Oncology, Cell Therapy, SARS-CoV-2, Coronavirus, COVID-19, Liver Disease Medicines, Cardiovascular, Inflammat... read more
Vaccines and Therapeutics
Vaccines and Therapeutics
Remdesivir Antiviral Drug
Available Contractsno information
Supplier Typeno information
Delivery Lead Timeno information
Contact Infono informationno information
Size and Minority Status
- Products and services 2
- Сommodity codes 3
Hematology/Oncology/Cell Therapy, Cardiovascular Diseases, and Inflammation/Respiratory Diseases.
Gilead Sciences provides FDA approved medicines/drugs for HIV/AIDS, Liver Disease, Hematology/Oncology/Cell Therapy, Cardiovascular Diseases, and Inflammation/Respiratory Diseases.
viruses, including Ebola and CoV. It is a nucleotide analog inhibitor of RNA-dependent RNA
Remdesivir is an investigational broad-spectrum antiviral agent with in vitro activity against multiple RNA viruses, including Ebola and CoV. It is a nucleotide analog inhibitor of RNA-dependent RNA polymerases.
U.S. FDA Grants Investigational New Drug Authorization to Gilead Science's Remdesivir. Gilead Science has started a randomized, open-label Phase 3 trial to evaluate remdesivir in patients with moderate in 600 patients and severe in 400 patients for COVID-19. The trial is going to take place in Hong Kong, Singapore, South Korea and the U.S. by enrolling patients in March, with results to come in May.
Authorization to Gilead Science's Remdesivir.
Gilead Science has started a randomized, ope...
active agent against both influenza A and B.
Influenza virus transcription occurs by a unique ...
RNA affinity cleavage reagents for commercial
use in humans as antiviral (including anti-HIV) a...
inhibitor, is an effective coagulant, but its use can
be limited by heparin-induced thrombocytopeni...
Existing Contracts 1
Locations Served 5
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.